🟢 Moleculin Biotech is trading 5.23% up today with no clear catalyst identified

Moleculin Biotech is trading 5.23% up at $0.81, with no clear company-specific catalyst identified for September 10, 2026.

• The latest listed company release was its August 27 investor-conference participation.
• September MIRACLE enrollment remains a forward-looking milestone.
• The broader market is lower amid hotter inflation data, making the move appear isolated; its cause remains unclear.